1
|
Aranega-Bou P, Cornbill C, Rodger G, Bird M, Moore G, Roohi A, Hopkins KL, Hopkins S, Ribeca P, Stoesser N, Lipworth SI. WITHDRAWN: Evaluation of Fourier Transform Infrared spectroscopy (IR Biotyper) as a complement to Whole genome sequencing (WGS) to characterise Enterobacter cloacae , Citrobacter freundii and Klebsiella pneumoniae isolates recovered from hospital sinks. medRxiv 2024:2023.04.24.23289028. [PMID: 37214917 PMCID: PMC10193520 DOI: 10.1101/2023.04.24.23289028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The authors have withdrawn their manuscript due to becoming aware of methodology issues related to the curation of the training set used to determine cut-off values for Biotyper cluster assignation and lack of replicate measurements on different days for the isolates analysed. It is therefore unclear whether the conclusions of the manuscript are founded and no further work is possible to correct these issues as the instrument is no longer available to the authors. If you have any questions, please contact the corresponding author.
Collapse
|
2
|
Rodger G, Chau K, Aranega-Bou P, Roohi A, Moore G, Hopkins KL, Hopkins S, Walker AS, Stoesser N. A workflow for the detection of antibiotic residues, measurement of water chemistry and preservation of hospital sink drain samples for metagenomic sequencing. J Hosp Infect 2024; 144:128-136. [PMID: 38145816 DOI: 10.1016/j.jhin.2023.11.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/27/2023] [Accepted: 11/30/2023] [Indexed: 12/27/2023]
Abstract
BACKGROUND Hospital sinks are environmental reservoirs that harbour healthcare-associated (HCA) pathogens. Selective pressures in sink environments, such as antibiotic residues, nutrient waste and hardness ions, may promote antibiotic resistance gene (ARG) exchange between bacteria. However, cheap and accurate sampling methods to characterize these factors are lacking. AIMS To validate a workflow to detect antibiotic residues and evaluate water chemistry using dipsticks. Secondarily, to validate boric acid to preserve the taxonomic and ARG ('resistome') composition of sink trap samples for metagenomic sequencing. METHODS Antibiotic residue dipsticks were validated against serial dilutions of ampicillin, doxycycline, sulfamethoxazole and ciprofloxacin, and water chemistry dipsticks against serial dilutions of chemical calibration standards. Sink trap aspirates were used for a 'real-world' pilot evaluation of dipsticks. To assess boric acid as a preservative of microbial diversity, the impact of incubation with and without boric acid at ∼22 °C on metagenomic sequencing outputs was evaluated at Day 2 and Day 5 compared with baseline (Day 0). FINDINGS The limits of detection for each antibiotic were: 3 μg/L (ampicillin), 10 μg/L (doxycycline), 20 μg/L (sulfamethoxazole) and 8 μg/L (ciprofloxacin). The best performing water chemistry dipstick correctly characterized 34/40 (85%) standards in a concentration-dependent manner. One trap sample tested positive for the presence of tetracyclines and sulphonamides. Taxonomic and resistome composition were largely maintained after storage with boric acid at ∼22 °C for up to five days. CONCLUSIONS Dipsticks can be used to detect antibiotic residues and characterize water chemistry in sink trap samples. Boric acid was an effective preservative of trap sample composition, representing a low-cost alternative to cold-chain transport.
Collapse
Affiliation(s)
- G Rodger
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Health Protection Unit in Antimicrobial Resistance and Healthcare-associated Infection, University of Oxford, Oxford, UK
| | - K Chau
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Health Protection Unit in Antimicrobial Resistance and Healthcare-associated Infection, University of Oxford, Oxford, UK
| | - P Aranega-Bou
- Biosafety, Air and Water Microbiology Group, UK Health Security Agency, Porton Down, UK
| | - A Roohi
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Health Protection Unit in Antimicrobial Resistance and Healthcare-associated Infection, University of Oxford, Oxford, UK
| | - G Moore
- Biosafety, Air and Water Microbiology Group, UK Health Security Agency, Porton Down, UK
| | | | - S Hopkins
- UK Health Security Agency, Colindale, UK
| | - A S Walker
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Health Protection Unit in Antimicrobial Resistance and Healthcare-associated Infection, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK
| | - N Stoesser
- Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Health Protection Unit in Antimicrobial Resistance and Healthcare-associated Infection, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
| |
Collapse
|
3
|
Richardson SAC, Anderson D, Burrell AJC, Byrne T, Coull J, Diehl A, Gantner D, Hoffman K, Hooper A, Hopkins S, Ihle J, Joyce P, Le Guen M, Mahony E, McGloughlin S, Nehme Z, Nickson CP, Nixon P, Orosz J, Riley B, Sheldrake J, Stub D, Thornton M, Udy A, Pellegrino V, Bernard S. Pre-hospital ECPR in an Australian metropolitan setting: a single-arm feasibility assessment-The CPR, pre-hospital ECPR and early reperfusion (CHEER3) study. Scand J Trauma Resusc Emerg Med 2023; 31:100. [PMID: 38093335 PMCID: PMC10717258 DOI: 10.1186/s13049-023-01163-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 11/30/2023] [Indexed: 12/17/2023] Open
Abstract
INTRODUCTION Survival from refractory out of hospital cardiac arrest (OHCA) without timely return of spontaneous circulation (ROSC) utilising conventional advanced cardiac life support (ACLS) therapies is dismal. CHEER3 was a safety and feasibility study of pre-hospital deployed extracorporeal membrane oxygenation (ECMO) during cardiopulmonary resuscitation (ECPR) for refractory OHCA in metropolitan Australia. METHODS This was a single jurisdiction, single-arm feasibility study. Physicians, with pre-existing ECMO expertise, responded to witnessed OHCA, age < 65 yrs, within 30 min driving-time, using an ECMO equipped rapid response vehicle. If pre-hospital ECPR was undertaken, patients were transported to hospital for investigations and therapies including emergent coronary catheterisation, and standard intensive care (ICU) therapy until either cardiac and neurological recovery or palliation occurred. Analyses were descriptive. RESULTS From February 2020 to May 2023, over 117 days, the team responded to 709 "potential cardiac arrest" emergency calls. 358 were confirmed OHCA. Time from emergency call to scene arrival was 27 min (15-37 min). 10 patients fulfilled the pre-defined inclusion criteria and all were successfully cannulated on scene. Time from emergency call to ECMO initiation was 50 min (35-62 min). Time from decision to ECMO support was 16 min (11-26 min). CPR duration was 46 min (32-62 min). All 10 patients were transferred to hospital for investigations and therapy. 4 patients (40%) survived to hospital discharge neurologically intact (CPC 1/2). CONCLUSION Pre-hospital ECPR was feasible, using an experienced ECMO team from a single-centre. Overall survival was promising in this highly selected group. Further prospective studies are now warranted.
Collapse
Affiliation(s)
- S A C Richardson
- The Alfred Hospital, Melbourne, Australia.
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
| | - D Anderson
- The Alfred Hospital, Melbourne, Australia
- Ambulance Victoria, Melbourne, Australia
- Department of Paramedicine, Monash University, Melbourne, Australia
| | - A J C Burrell
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - T Byrne
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - J Coull
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - A Diehl
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - D Gantner
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - K Hoffman
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - A Hooper
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - S Hopkins
- Ambulance Victoria, Melbourne, Australia
| | - J Ihle
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - P Joyce
- The Alfred Hospital, Melbourne, Australia
| | - M Le Guen
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - E Mahony
- Ambulance Victoria, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - S McGloughlin
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - Z Nehme
- Ambulance Victoria, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - C P Nickson
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - P Nixon
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - J Orosz
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - B Riley
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | | | - D Stub
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - M Thornton
- Ambulance Victoria, Melbourne, Australia
| | - A Udy
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - V Pellegrino
- The Alfred Hospital, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| | - S Bernard
- The Alfred Hospital, Melbourne, Australia
- Ambulance Victoria, Melbourne, Australia
- Department of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
| |
Collapse
|
4
|
Higgins H, Freeman R, Doble A, Hood G, Islam J, Gerver S, Henderson KL, Demirjian A, Hopkins S, Ashiru-Oredope D. Appropriateness of acute-care antibiotic prescriptions for community-acquired infections and surgical antibiotic prophylaxis in England: analysis of 2016 national point prevalence survey data. J Hosp Infect 2023; 142:115-129. [PMID: 37858806 DOI: 10.1016/j.jhin.2023.10.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 10/03/2023] [Accepted: 10/03/2023] [Indexed: 10/21/2023]
Abstract
BACKGROUND Estimates of inappropriate prescribing can highlight key target areas for antimicrobial stewardship (AMS) and inform national targets. OBJECTIVES To (1) define and (2) produce estimates of inappropriate antibiotic prescribing levels within acute hospital trusts in England. METHODS The 2016 national Healthcare-Associated Infections (HAI), Antimicrobial Use (AMU) and AMS point prevalence survey (PPS) was used to derive estimates of inappropriate prescribing, focusing on the four most reported community-acquired antibiotic indications (CAIs) in the PPS and surgical prophylaxis. Definitions of appropriate antibiotic therapy for each indication were developed through the compilation of national treatment guidelines. A Likert-scale system of appropriateness coding was validated and refined through a two-stage expert review process. RESULTS Antimicrobial usage prevalence data were collected for 25,741 individual antibiotic prescriptions, representing 17,884 patients and 213 hospitals in England. 30.4% of prescriptions for the four CAIs of interest were estimated to be inappropriate (2054 prescriptions). The highest percentage of inappropriate prescribing occurred in uncomplicated cystitis prescriptions (62.5%), followed by bronchitis (48%). For surgical prophylaxis, 30.8% of prescriptions were inappropriate in terms of dose number, and 21.3% in terms of excess prophylaxis duration. CONCLUSIONS The 2016 prevalence of inappropriate antibiotic prescribing in hospitals in England was approximated to be 30.4%; this establishes a baseline prevalence and provided indication of where AMS interventions should be prioritized. Our definitions appraised antibiotic choice, treatment duration and dose number (surgical prophylaxis only); however, they did not consider other aspects of appropriateness, such as combination therapy - this is an important area for future work.
Collapse
Affiliation(s)
- H Higgins
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK.
| | - R Freeman
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK; IQVIA, London, UK
| | - A Doble
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK; Health Education England North West, Manchester, UK
| | - G Hood
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK; NHS England (Midlands), Birmingham, UK
| | - J Islam
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK
| | - S Gerver
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK
| | - K L Henderson
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK
| | - A Demirjian
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK; Department of Paediatric Infectious Diseases & Immunology, Evelina London Children's Hospital, London, UK; Faculty of Life Sciences & Medicine, King's College London, London, UK
| | - S Hopkins
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK
| | - D Ashiru-Oredope
- Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use & Sepsis Division, United Kingdom Health Security Agency (UKHSA, Previously Public Health England (PHE)), London, UK
| |
Collapse
|
5
|
Henderson KL, Saei A, Freeman R, Johnson AP, Ashiru-Oredope D, Gerver SM, Hopkins S. Intermittent point prevalence surveys on healthcare-associated infections, 2011 and 2016, in England: what are the surveillance and intervention priorities? J Hosp Infect 2023; 140:24-33. [PMID: 37532196 DOI: 10.1016/j.jhin.2023.07.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 07/12/2023] [Accepted: 07/20/2023] [Indexed: 08/04/2023]
Abstract
BACKGROUND Point prevalence surveys are an important surveillance method for determining the burden of healthcare-associated infections (HCAIs). AIM To outline the key results of two point prevalence surveys in England (2011 and 2016). METHODS All National Health Service and independent sector hospitals in England were eligible to participate. Data were collected between September and November in both 2011 and 2016 based on the protocol and codebook devised by the European Centre for Disease Prevention and Control. Analysis was performed using Stata Version 13 and SAS Version 9.3. A mixed-effects model was applied, which allowed estimation of organization-specific means and accounted for the heterogeneity in the responses from different organizations. FINDINGS A total of 100,755 case records were included (52,433 in 2011 and 48,312 in 2016). The estimated prevalence of HCAIs was slightly higher in 2016 [6.89%, 95% confidence interval (CI) 6.21-7.57%] than in 2011 (6.41%, 95% CI 5.75-7.06%). In both surveys, the prevalence of HCAIs was highest in adult intensive care units (23.1% in 2011, 21.2% in 2016), and pneumonia/lower respiratory tract infections was the most common cause of HCAIs (22.7% in 2011 vs 29.2% in 2016). Inpatients in acute hospitals were older and had higher risk of dying in 2016 compared with 2011; however, the proportion of inpatients with HCAIs or on antibiotics did not differ significantly. CONCLUSION The burden of HCAIs in English hospitals increased slightly between 2011 and 2016. However, the proportion of inpatients with HCAIs or on antibiotics did not differ significantly.
Collapse
Affiliation(s)
- K L Henderson
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK.
| | - A Saei
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK
| | - R Freeman
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK
| | - A P Johnson
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK
| | - D Ashiru-Oredope
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK
| | - S M Gerver
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK
| | - S Hopkins
- HCAI, Fungal, AMR, AMU and Sepsis Division, UK Health Security Agency, London, UK
| |
Collapse
|
6
|
Smith EC, Hopkins S, Case LE, Xu M, Walters C, Dearmey S, Han SO, Spears TG, Chichester JA, Bossen EH, Hornik CP, Cohen JL, Bali D, Kishnani PS, Koeberl DD. Phase I study of liver depot gene therapy in late-onset Pompe disease. Mol Ther 2023; 31:1994-2004. [PMID: 36805083 PMCID: PMC10362382 DOI: 10.1016/j.ymthe.2023.02.014] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 01/03/2023] [Accepted: 02/16/2023] [Indexed: 02/21/2023] Open
Abstract
Gene therapy with an adeno-associated virus serotype 8 (AAV8) vector (AAV8-LSPhGAA) could eliminate the need for enzyme replacement therapy (ERT) by creating a liver depot for acid α-glucosidase (GAA) production. We report initial safety and bioactivity of the first dose (1.6 × 1012 vector genomes/kg) cohort (n = 3) in a 52-week open-label, single-dose, dose-escalation study (NCT03533673) in patients with late-onset Pompe disease (LOPD). Subjects discontinued biweekly ERT after week 26 based on the detection of elevated serum GAA activity and the absence of clinically significant declines per protocol. Prednisone (60 mg/day) was administered as immunoprophylaxis through week 4, followed by an 11-week taper. All subjects demonstrated sustained serum GAA activities from 101% to 235% of baseline trough activity 2 weeks following the preceding ERT dose. There were no treatment-related serious adverse events. No subject had anti-capsid T cell responses that decreased transgene expression. Muscle biopsy at week 24 revealed unchanged muscle glycogen content in two of three subjects. At week 52, muscle GAA activity for the cohort was significantly increased (p < 0.05). Overall, these initial data support the safety and bioactivity of AAV8-LSPhGAA, the safety of withdrawing ERT, successful immunoprophylaxis, and justify continued clinical development of AAV8-LSPhGAA therapy in Pompe disease.
Collapse
Affiliation(s)
- Edward C Smith
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Sam Hopkins
- Asklepios Biopharmaceutical, Inc. (Askbio), Durham, NC, USA
| | - Laura E Case
- Department of Orthopedics, Duke University School of Medicine, Durham, NC, USA
| | - Ming Xu
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Crista Walters
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Stephanie Dearmey
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Sang-Oh Han
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Tracy G Spears
- Clinical Trials Statistics, Duke Clinical Research Institute, Durham, NC, USA
| | - Jessica A Chichester
- Immunology Core, Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Edward H Bossen
- Department of Pathology, Duke University Medical Center, Durham, NC, USA
| | - Christoph P Hornik
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Jennifer L Cohen
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Deeksha Bali
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Priya S Kishnani
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA
| | - Dwight D Koeberl
- Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
| |
Collapse
|
7
|
Blake D, Patel A, Hopkins S, Pozo AD, Marx J, Ibrahim M, Hamad E. Pseudo Cardiomyopathy in End-Stage Lung Disease With Elevated Pulmonary Vascular Resistance and/or Right Ventricular Dysfunction That Improves Following Lung Transplantation. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
8
|
Atti A, Ferrari M, Castillo-Olivares J, Monk E, Gopal R, Patel M, Hoschler K, Cole M, Semper A, Hewson J, Otter A, Foulkes S, Islam J, Mirfenderesky M, Jain S, Murira J, Favager C, Nastouli E, Chand M, Brown C, Heeney J, Brooks T, Hall V, Hopkins S, Zambon M. Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study. J Infect 2022; 84:248-288. [PMID: 34600935 PMCID: PMC8482544 DOI: 10.1016/j.jinf.2021.09.019] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Accepted: 09/26/2021] [Indexed: 12/15/2022]
Affiliation(s)
- A. Atti
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK,Correspondence author
| | - M. Ferrari
- Department of Veterinary Medicine, Laboratory of Viral Zoonotics (LVZ) and HICC (Humoral Immune Correlates from COVID-19), University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK
| | - J. Castillo-Olivares
- Department of Veterinary Medicine, Laboratory of Viral Zoonotics (LVZ) and HICC (Humoral Immune Correlates from COVID-19), University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK
| | - E.J.M. Monk
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - R. Gopal
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - M. Patel
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - K. Hoschler
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - M.J. Cole
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - A. Semper
- Public Health England (PHE), Porton Down, Salisbury SP4 0JG, UK
| | - J. Hewson
- Public Health England (PHE), Porton Down, Salisbury SP4 0JG, UK
| | - A.D. Otter
- Public Health England (PHE), Porton Down, Salisbury SP4 0JG, UK
| | - S. Foulkes
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - J. Islam
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - M. Mirfenderesky
- North Middlesex University Hospital NHS Trust, Sterling Way, London N18 1QX, UK
| | - S. Jain
- North Middlesex University Hospital NHS Trust, Sterling Way, London N18 1QX, UK
| | - J. Murira
- Leeds Teaching Hospitals NHS Trust, Great George St, Leeds LS1 3EX, UK
| | - C. Favager
- Leeds Teaching Hospitals NHS Trust, Great George St, Leeds LS1 3EX, UK
| | - E. Nastouli
- Department of Clinical Virology, University College London Hospitals NHS Foundation Trust, 250 Euston Rd, London NW1 2PG, UK,Department of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, 30 Guilford St, London WC1N 1EH, UK
| | - M.A. Chand
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - C.S. Brown
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - J.L. Heeney
- Department of Veterinary Medicine, Laboratory of Viral Zoonotics (LVZ) and HICC (Humoral Immune Correlates from COVID-19), University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK
| | - T. Brooks
- Public Health England (PHE), Porton Down, Salisbury SP4 0JG, UK
| | - V.J. Hall
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - S. Hopkins
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| | - M. Zambon
- Public Health England (PHE), PHE Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
| |
Collapse
|
9
|
Ashiru-Oredope D, Budd EL, Doble A, Cramp E, Hendrick A, Hopkins S. Development and implementation of a national antimicrobial stewardship surveillance system, with open access data sharing. J Hosp Infect 2020; 107:16-22. [PMID: 33122043 DOI: 10.1016/j.jhin.2020.10.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 10/19/2020] [Accepted: 10/21/2020] [Indexed: 11/24/2022]
Abstract
BACKGROUND Public Health England (PHE) developed an antimicrobial stewardship (AMS) surveillance system and conducted a national pilot to test the feasibility of centrally collecting data from AMS audits performed by NHS hospital trusts. The system was simplified, focusing on requirements of the NHS AMR CQUIN (Commissioning for Quality and Innovation; a financial incentive quality improvement scheme). AIM To present results and user feedback from the national pilot, and results from using the AMS surveillance system as part of the AMR CQUIN. METHODS An AMS surveillance system was developed and a national pilot conducted in which 33 NHS trusts submitted data and feedback on system utilization. The system was refined based on feedback and deployed nationally to collect AMS data for the 2016-17 AMR CQUIN. FINDINGS Most trusts participating in the pilot collected data on documentation of indication (90%). Fewer collected data on documenting review decisions at 48-72 h (36%). On average 83% of patients had an indication documented, whereas 71% had formal documentation of 48-72 h review. AMR CQUIN data were submitted by 88% of trusts for at least one quarter of 2016-17. Approximately 92% of prescriptions had an indication documented and 87.5% of prescriptions had evidence of review within 72 h; these increased by 7 and 10 percentage points respectively between the first and final quarters. CONCLUSION The AMS surveillance system allowed AMS audit data from NHS trusts in England to be collected centrally. PHE publishes these data openly online, on PHE Fingertips portal, a national public health data portal. The reported data highlight improvement in the percentage of antibiotic prescriptions with evidence of a documented review within 72 h.
Collapse
Affiliation(s)
- D Ashiru-Oredope
- HCAI & AMR Division, National Infection Service, Public Health England, London, UK.
| | - E L Budd
- HCAI & AMR Division, National Infection Service, Public Health England, London, UK
| | - A Doble
- HCAI & AMR Division, National Infection Service, Public Health England, London, UK
| | - E Cramp
- Patient Safety Team, NHS Improvement, London, UK(1)
| | - A Hendrick
- HCAI & AMR Division, National Infection Service, Public Health England, London, UK
| | - S Hopkins
- HCAI & AMR Division, National Infection Service, Public Health England, London, UK
| |
Collapse
|
10
|
Chi DL, Mancl L, Hopkins S, Randall CL, Orr E, Zahlis E, Dunbar M, Lenaker D, Babb M. Supply of care by dental therapists and emergency dental consultations in Alaska native communities in the Yukon-Kuskokwim delta: a mixed methods evaluation. Community Dent Health 2020; 37:190-198. [PMID: 32673470 DOI: 10.1922/cdh_00022chi09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
OBJECTIVES Examine the relationship between supply of care provided by dental therapists and emergency dental consultations in Alaska Native communities. METHODS Explanatory sequential mixed-methods study using Alaska Medicaid and electronic health record (EHR) data from the Yukon-Kuskokwim Health Corporation (YKHC), and interview data from six Alaska Native communities. From the Medicaid data, we estimated community-level dental therapy treatment days and from the EHR data we identified emergency dental consultations. We calculated Spearman partial correlation coefficients and ran confounder-adjusted models for children and adults. Interview data collected from YKHC providers (N=16) and community members (N=125) were content analysed. The quantitative and qualitative data were integrated through connecting. Results were visualized with a joint display. RESULTS There were significant negative correlations between dental therapy treatment days and emergency dental consultations for children (partial rank correlation = -0.48; p⟨0.001) and for adults (partial rank correlation = -0.18; p=0.03). Six pediatric themes emerged: child-focused health priorities; school-based dental programs; oral health education and preventive behaviors; dental care availability; healthier teeth; and satisfaction with care. There were four adult themes: satisfaction with care; adults as a lower priority; difficulties getting appointments; and limited scope of practice of dental therapy. CONCLUSIONS Alaska Native children, and to a lesser extent adults, in communities served more intensively by dental therapists have benefitted. There are high levels of unmet dental need as evidenced by high emergency dental consultation rates. Future research should identify ways to address unmet dental needs, especially for adults.
Collapse
Affiliation(s)
- D L Chi
- University of Washington, Department of Oral Health Sciences, Seattle, WA, USA
- University of Washington, Department of Health Services, Seattle, WA, USA
| | - L Mancl
- University of Washington, Department of Oral Health Sciences, Seattle, WA, USA
| | - S Hopkins
- Oregon Health and Science University, Department of Obstetrics and Gynecology, Portland, OR
| | - C L Randall
- University of Washington, Department of Oral Health Sciences, Seattle, WA, USA
| | - E Orr
- University of Washington, Department of Oral Health Sciences, Seattle, WA, USA
| | - E Zahlis
- University of Washington, Department of Oral Health Sciences, Seattle, WA, USA
| | - M Dunbar
- University of Washington, Center for Studies in Demography and Ecology, Seattle, WA, USA
| | - D Lenaker
- Southeast Alaska Regional Health Consortium, Dental Department, Sitka, AK
| | - M Babb
- University of Washington, Center for Studies in Demography and Ecology, Seattle, WA, USA
| |
Collapse
|
11
|
Nelson D, Edwards S, Ennis O, Morgan A, Samir H, Davies P, Hopkins S. Musculoskeletal MRI requesting is an overused resource: can a multi-disciplinary group reduced inappropriate referrals from primary care to secondary care? Physiotherapy 2020. [DOI: 10.1016/j.physio.2020.03.256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Hopkins S, La Gerche A, Stub D, Parsons S, Ball J, Thompson T, Morgan N, Zentner D, Pflaumer A, James P, Bernard S, Paratz E, Rowsell L, Smith K. 608 Incidence and Epidemiology of Sudden Cardiac Arrest In Younger Persons. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Feldsine PT, Leung SC, Lienau AH, Mui LA, Townsend DE, Arling V, August L, Barham D, Bohnert M, Boville A, Brookman S, Chavey C, Clements S, Davis R, Devane S, Dissel S, Gartside S, Hagel D, Hernandez C, Hopkins S, Howell M, Humbert F, Hunsucker J, Jackson J, Koch S, Kuber C, Lamb J, Lewis L, Lightfoot B, Lin W, Musch S, Nieves K, Poumeyrol M, Qvist S, Rice J, Solis D, Terry J, in’t Veld P, Voermans R, Warburton D, Welch J. Enumeration of Total Aerobic Microorganisms in Foods by SimPlate® Total Plate Count–Color Indicator Methods and Conventional Culture Methods: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/86.2.257] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
The relative efficacy of the SimPlate® Total Plate Count–Color Indicator (TPC–CI) method (SimPlate 35°C) was compared with the AOAC Official Method 966.23 (AOAC 35°C) for enumeration of total aerobic microorganisms in foods. The SimPlate TPC–CI method, incubated at 30°C (SimPlate 30°C), was also compared with the International Organization for Standardization (ISO) 4833 method (ISO 30°C). Six food types were analyzed: ground black pepper, flour, nut meats, frozen hamburger patties, frozen fruits, and fresh vegetables. All foods tested were naturally contaminated. Nineteen laboratories throughout North America and Europe participated in the study. Three method comparisons were conducted. In general, there was <0.3 mean log count difference in recovery among the SimPlate methods and their corresponding reference methods. Mean log counts between the 2 reference methods were also very similar. Repeatability (sr) and reproducibility (sR) standard deviations were similar among the 3 method comparisons. The SimPlate method (35°C) and the AOAC method were comparable for enumerating total aerobic microorganisms in foods. Similarly, the SimPlate method (30°C) was comparable to the ISO method when samples were prepared and incubated according to the ISO method.
Collapse
Affiliation(s)
| | | | - Andrew H Lienau
- BioControl Systems Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | - Linda A Mui
- BioControl Systems Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Feldsine PT, Kerr DE, Leung SC, Lienau AH, Moser RF, Mui LA, Anderson G, Beasley M, Clements S, Dillon J, Dombroski P, Forgey R, Gartside S, Hernandez C, Hopkins S, Johnson K, Meier J, Nguyen T, Ortega R, Reynolds J, Smith J, Solis D, Summers C, Terry J, Tuncan E, Vrana D, Warren W, Wood S. Visual Immunoprecipitate Assay Eight Hour Method for Detection of Enterohemorrhagic Escherichia coli O157:H7 in Raw and Cooked Beef (Modification of AOAC Official Method 996.09): Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/85.5.1029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
AOAC Official Method 996.09, Visual Immunoprecipitate Assay (VIP®) for Escherichia coli O157:H7, was modified to incorporate a new enrichment protocol using BioControl EHEC8™ medium for testing raw and cooked beef. Foods were tested by VIP assay and the U.S. Department of Agriculture/Food Safety and Inspection Service (USDA/FSIS) enrichment procedure and the FDA Bacteriological Analytical Manual (BAM) isolation and confirmation techniques. A total of 15 collaborators participated. Raw and cooked ground beef were inoculated with E. coli O157:H7 at 2 different levels: a high level, where predominantly positive results were expect d, and a low level where fractional recovery was anticipated. Collaborators tested 396 test portions and controls by both methods, for a total of 792 test portions. Of the 396 paired test portions, 75 were positive and 230 were negative by both the VIP and culture methods. Eleven test portions were presumptively positive by VIP and could not be confirmed culturally; 32 were negative by VIP, but confirmed positive by culture; and 65 were negative by the culture method, but confirmed positive by the VIP method. There was no statistical difference between results obtained with the VIP for EHEC 8 h method and the culture method except for cooked beef, where the VIP had significantly higher recovery for one inoculation level.
Collapse
Affiliation(s)
| | - David E Kerr
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | - Andrew H Lienau
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | - Ruth F Moser
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | - Linda A Mui
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Feldsine PT, Kerr DE, Leung SC, Lienau AH, Miller SM, Mui LA, Anderson G, Beasley M, Dillon J, Dombroski P, Forgey R, Hernandez C, Hopkins S, Johnson K, Meier J, Nguyen T, Ortega R, Reynolds J, Smith J, Solis D, Summers C, Terry J, Tuncan E, Vrana D, Warren W, Wood S. Assurance® Enzyme Immunoassay Eight Hour Method for Detection of Enterohemorrhagic Escherichia coli O157:H7 in Raw and Cooked Beef (Modification of AOAC Official Method 996.10): Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/85.5.1037] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
AOAC Official Method 996.10, Assurance® Enzyme Immunoassay (EIA) for Escherichia coli O157:H7 (EHEC), was modified to incorporate a new enrichment protocol using BioControl EHEC8™ medium for testing raw and cooked beef. Foods were tested by EIA and the U.S. Department of Agriculture/Food Safety and Inspection Service (USDA/FSIS) enrichment conditions and the FDA Bacteriological Analytical Manual (BAM) isolation and confirmation techniques. A total of 14 collaborators participated. Raw and cooked ground beef were inoculated with E. coli O157:H7 at 2 different levels: a high level where predominantly positive results were expected, and a low level where fractional recovery was anticipated. Collaborators tested 378 test portions and controls by both the 8 h EIA and the USDA/FSIS enrichment methods, for a total of 756 test portions. Of the 378 paired test portions, 75 were positive and 212 were negative by both methods. Thirteen test portions were presumptively positive by EIA and could not be confirmed culturally; 30 were negative by EIA, but confirmed positive by culture; and 65 were negative by the culture method, but confirmed positive by the EIA method. There was no statistical difference between results obtained with the Assurance EIA for EHEC 8 h method and the culture method for raw ground beef. The Assurance EIA had a significantly higher recovery for cooked beef.
Collapse
Affiliation(s)
| | - David E Kerr
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | - Andrew H Lienau
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | - Linda A Mui
- BioControl Systems, Inc., 12822 SE 32nd St, Bellevue, WA 98005
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Birgand G, Troughton R, Mariano V, Hettiaratchy S, Hopkins S, Otter JA, Holmes A. How do surgeons feel about the 'Getting it Right First Time' national audit? Results from a qualitative assessment. J Hosp Infect 2019; 104:328-331. [PMID: 31711792 DOI: 10.1016/j.jhin.2019.11.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2019] [Accepted: 11/01/2019] [Indexed: 11/29/2022]
Abstract
The implementation of the national 'Getting It Right First Time' was assessed by interviewing six surgeons involved at various levels in surgical site infection (SSI) audit. The positive impacts were to create new professional collaboration, improve stakeholder engagement, and increase the profile of SSIs. One particular knowledge gap highlighted was that some participants had been unaware until that point of the criteria for diagnosing an SSI. The quality of data collected was felt to be poor due to methodological flaws. The audit was described as highly time-consuming and unsustainable if leaning on junior surgeons, without protected time and designated responsibility.
Collapse
Affiliation(s)
- G Birgand
- National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, London, UK.
| | - R Troughton
- National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, London, UK
| | - V Mariano
- National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, London, UK
| | - S Hettiaratchy
- Major Trauma Centre, St Mary's Hospital, Imperial College Healthcare NHS Trust, Praed Street, London, UK
| | - S Hopkins
- National Infection Service, Public Health England, London, UK
| | - J A Otter
- Infection Control, Imperial College Healthcare NHS Trust, London, UK
| | - A Holmes
- National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, London, UK
| |
Collapse
|
17
|
Bleiker J, Morgan-Trimmer S, Knapp K, Hopkins S. Navigating the maze: Qualitative research methodologies and their philosophical foundations. Radiography (Lond) 2019; 25 Suppl 1:S4-S8. [DOI: 10.1016/j.radi.2019.06.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2019] [Revised: 06/24/2019] [Accepted: 06/26/2019] [Indexed: 10/26/2022]
|
18
|
Islam J, Ashiru-Oredope D, Budd E, Howard P, Walker AS, Hopkins S, Llewelyn MJ. A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact. J Antimicrob Chemother 2019; 73:1708-1713. [PMID: 29506043 DOI: 10.1093/jac/dky041] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2017] [Accepted: 01/20/2018] [Indexed: 11/13/2022] Open
Abstract
Background In 2016/2017, a financially linked antibiotic prescribing quality improvement initiative Commissioning for Quality and Innovation (AMR-CQUIN) was introduced across acute hospitals in England. This aimed for >1% reductions in DDDs/1000 admissions of total antibiotics, piperacillin/tazobactam and carbapenems compared with 2013/2014 and improved review of empirical antibiotic prescriptions. Objectives To assess perceptions of staff leading antimicrobial stewardship activity regarding the AMR-CQUIN, the investments made by hospitals to achieve it and how these related to achieving reductions in antibiotic use. Methods We invited antimicrobial stewardship leads at acute hospitals across England to complete a web-based survey. Antibiotic prescribing data were downloaded from the PHE Antimicrobial Resistance Local Indicators resource. Results Responses were received from 116/155 (75%) acute hospitals. Owing to yearly increases in antibiotic use, most trusts needed to make >5% reductions in antibiotic consumption to achieve the AMR-CQUIN goal of 1% reduction. Additional funding was made available at 23/113 (20%) trusts and, in 18 (78%), this was <10% of the AMR-CQUIN value. Nationally, the annual trend for increased antibiotic use reversed in 2016/2017. In 2014/2015, year-on-year changes were +3.7% (IQR -0.8%, +8.4%), +9.4% (+0.2%, +19.5%) and +5.8% (-6.2%, +18.2%) for total antibiotics, piperacillin/tazobactam and carbapenems, respectively, and +0.1% (-5.4%, +4.0%), -4.8% (-16.9%, +3.2%) and -8.0% (-20.2%, +4.0%) in 2016/2017. Hospitals where staff believed they could reduce antibiotic use were more likely to do so (P < 0.001). Conclusions Introducing the AMR-CQUIN was associated with a reduction in antibiotic use. For individual hospitals, achieving the AMR-CQUIN was associated with favourable perceptions of staff and not availability of funding.
Collapse
Affiliation(s)
- J Islam
- Department of Microbiology and Infection, Brighton and Sussex University Hospitals NHS Trust, Brighton BN2 5BE, UK.,Department of Global Health and Infection, Brighton and Sussex Medical School, Falmer BN1 9PS, UK
| | - D Ashiru-Oredope
- AMR Programme, Public Health England, Wellington House, 133-155 Waterloo Rd, London SE1 8UG, UK
| | - E Budd
- AMR Programme, Public Health England, Wellington House, 133-155 Waterloo Rd, London SE1 8UG, UK
| | - P Howard
- Department of Medicines Management and Pharmacy, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK.,Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, UK
| | - A S Walker
- Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
| | - S Hopkins
- AMR Programme, Public Health England, Wellington House, 133-155 Waterloo Rd, London SE1 8UG, UK
| | - M J Llewelyn
- Department of Microbiology and Infection, Brighton and Sussex University Hospitals NHS Trust, Brighton BN2 5BE, UK.,Department of Global Health and Infection, Brighton and Sussex Medical School, Falmer BN1 9PS, UK
| |
Collapse
|
19
|
Kotchetkov R, McLean J, Gerard L, Nay D, Hopkins S. IMPROVEMENT OF RITUXIMAB ADMINISTRATION BY PREMEDICATION WITH RUPATADINE, MONTELUKAST AND THEIR COMBINATION. Hematol Oncol 2019. [DOI: 10.1002/hon.149_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
| | - J. McLean
- Research; RVH Research Institute, Royal Victoria Regional Heath Centre; Barrie Canada
| | | | - D. Nay
- Oncology; SMRCP; Barrie Canada
| | - S. Hopkins
- Provincial Drug Reimbursement Programs; Cancer Care Ontario; Toronto Canada
| |
Collapse
|
20
|
Smith DRM, Pouwels KB, Hopkins S, Naylor NR, Smieszek T, Robotham JV. Epidemiology and health-economic burden of urinary-catheter-associated infection in English NHS hospitals: a probabilistic modelling study. J Hosp Infect 2019; 103:44-54. [PMID: 31047934 DOI: 10.1016/j.jhin.2019.04.010] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Accepted: 04/23/2019] [Indexed: 01/08/2023]
Abstract
BACKGROUND Catheter-associated urinary tract infection (CAUTI) and bloodstream infection (CABSI) are leading causes of healthcare-associated infection in England's National Health Service (NHS), but health-economic evidence to inform investment in prevention is lacking. AIMS To quantify the health-economic burden and value of prevention of urinary-catheter-associated infection among adult inpatients admitted to NHS trusts in 2016/17. METHODS A decision-analytic model was developed to estimate the annual prevalence of CAUTI and CABSI, and their associated excess health burdens [quality-adjusted life-years (QALYs)] and economic costs (£ 2017). Patient-level datasets and literature were synthesized to estimate population structure, model parameters and associated uncertainty. Health and economic benefits of catheter prevention were estimated. Scenario and probabilistic sensitivity analyses were conducted. FINDINGS The model estimated 52,085 [95% uncertainty interval (UI) 42,967-61,360] CAUTIs and 7529 (UI 6857-8622) CABSIs, of which 38,084 (UI 30,236-46,541) and 2524 (UI 2319-2956) were hospital-onset infections, respectively. Catheter-associated infections incurred 45,717 (UI 18,115-74,662) excess bed-days, 1467 (UI 1337-1707) deaths and 10,471 (UI 4783-13,499) lost QALYs. Total direct hospital costs were estimated at £54.4M (UI £37.3-77.8M), with an additional £209.4M (UI £95.7-270.0M) in economic value of QALYs lost assuming a willingness-to-pay threshold of £20,000/QALY. Respectively, CABSI accounted for 47% (UI 32-67%) and 97% (UI 93-98%) of direct costs and QALYs lost. Every catheter prevented could save £30 (UI £20-44) in direct hospital costs and £112 (UI £52-146) in QALY value. CONCLUSIONS Hospital catheter prevention is poised to reap substantial health-economic gains, but community-oriented interventions are needed to target the large burden imposed by community-onset infection.
Collapse
Affiliation(s)
- D R M Smith
- Modelling and Economics Unit, National Infection Service, Public Health England, London, UK; Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK; Pharmacoépidémiologie et Maladies Infectieuses, Institut Pasteur, U1181, Inserm, UVSQ, Paris, France; UVSQ, Université Paris-Saclay, Versailles, France; Laboratoire MESuRS, Conservatoire National des Arts et Métiers, Paris, France.
| | - K B Pouwels
- Modelling and Economics Unit, National Infection Service, Public Health England, London, UK; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK; Department of Health Sciences, Global Health, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands
| | - S Hopkins
- Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK; Directorate of Infection, Royal Free London NHS Foundation Trust, London, UK; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
| | - N R Naylor
- National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
| | - T Smieszek
- Modelling and Economics Unit, National Infection Service, Public Health England, London, UK; Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK
| | - J V Robotham
- Modelling and Economics Unit, National Infection Service, Public Health England, London, UK; Healthcare-Associated Infection and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, UK; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
| |
Collapse
|
21
|
Jermacane D, Coope CM, Ironmonger D, Cleary P, Muller-Pebody B, Hope R, Hopkins S, Puleston R, Freeman R, Hopkins KL, Johnson AP, Woodford N, Oliver I. An evaluation of the electronic reporting system for the enhanced surveillance of carbapenemase-producing Gram-negative bacteria in England. J Hosp Infect 2019; 102:17-24. [PMID: 30641097 DOI: 10.1016/j.jhin.2019.01.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2018] [Accepted: 01/03/2019] [Indexed: 01/04/2023]
Abstract
BACKGROUND An electronic reporting system (ERS) for the enhanced surveillance of carbapenemase-producing Gram-negative bacteria (CPGNB) was launched by Public Health England in May 2015. AIM This evaluation aimed to assess uptake, timeliness and completeness of data provided and explore potential barriers and facilitators to adopting the system. METHODS The evaluation comprised a retrospective analysis of surveillance data and semi-structured interviews with ERS users. FINDINGS The proportion of organisms referred for investigation of carbapenem resistance via ERS increased over the first 12 months post-implementation from 35% to 73%; uptake varied widely across regions of England. Completeness of enhanced data fields was poor in 78% of submitted isolates. The median number of days to report confirmatory test results via ERS was 1 day for the regional service and nine days for the national reference laboratory, which additionally conducts phenotypic testing to confirm carbapenemase negativity. Hindrances to ERS utility included: a lack of designated, ongoing resource for system maintenance, technical support and development; uncertainty about how and when to use ERS and workload. Incomplete data prevented gaining a better understanding of important risk factors and transmission routes of CPGNB in England. CONCLUSION The ERS is the only surveillance system in England with the potential to gather intelligence on important risk factors for CPGNB to inform public health measures to control their spread. Although the ERS captures more information on CPGNB than other surveillance systems, timeliness and completeness of the enhanced data require substantial improvements in order to deliver the desired health benefits.
Collapse
Affiliation(s)
- D Jermacane
- Field Service, National Infection Service, Public Health England, UK
| | - C M Coope
- Field Service, National Infection Service, Public Health England, UK; NIHR Health Protection Research Unit in Evaluation of Interventions, University of Bristol, Bristol, UK.
| | - D Ironmonger
- Field Service, National Infection Service, Public Health England, UK
| | - P Cleary
- Field Service, National Infection Service, Public Health England, UK
| | - B Muller-Pebody
- Division of Healthcare-Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, London, UK
| | - R Hope
- Division of Healthcare-Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, London, UK
| | - S Hopkins
- Division of Healthcare-Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, London, UK
| | - R Puleston
- Field Service, National Infection Service, Public Health England, UK
| | - R Freeman
- Division of Healthcare-Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, London, UK
| | - K L Hopkins
- Division of Healthcare-Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, London, UK
| | - A P Johnson
- Division of Healthcare-Associated Infection and Antimicrobial Resistance, National Infection Service, Public Health England, London, UK
| | - N Woodford
- National Infection Service Laboratories, Public Health England, London, UK
| | - I Oliver
- Field Service, National Infection Service, Public Health England, UK; NIHR Health Protection Research Unit in Evaluation of Interventions, University of Bristol, Bristol, UK
| |
Collapse
|
22
|
Troughton R, Birgand G, Johnson A, Naylor N, Gharbi M, Aylin P, Hopkins S, Jaffer U, Holmes A. Mapping national surveillance of surgical site infections in England: needs and priorities. J Hosp Infect 2018; 100:378-385. [DOI: 10.1016/j.jhin.2018.06.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Accepted: 06/06/2018] [Indexed: 10/14/2022]
|
23
|
Southern J, Sridhar S, Tsou CY, Hopkins S, Collier S, Nikolayevskyy V, Lozewicz S, Lalvani A, Abubakar I, Lipman M. Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease. Public Health 2018; 166:34-39. [PMID: 30439554 DOI: 10.1016/j.puhe.2018.09.023] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Revised: 09/18/2018] [Accepted: 09/25/2018] [Indexed: 11/18/2022]
Abstract
OBJECTIVES This natural experiment was designed to assess the impact of exposure to an active case of tuberculosis (TB) on a group of immunosuppressed individuals, with end-stage renal disease over an extended follow-up. STUDY DESIGN Close contacts of people with sputum smear-positive Mycobacterium tuberculosis are at high risk of infection, particularly immunosuppressed individuals. An infectious TB healthcare worker worked in a renal dialysis unit for a month before diagnosis, with 104 renal dialysis patients, was exposed for ≥8 h. METHODS Patients were informed and invited for screening 8-10 weeks postexposure. They either underwent standard two-step assessment with tuberculin skin test (TST) and QuantiFERON®-TB Gold (Cellestis GmbH; QFN) interferon-gamma release assay (IGRA) or after consent, enrolled in a study where these two tests were performed simultaneously with T-SPOT®-TB (Oxford Immunotec Ltd; TSPOT). Patients within the study were followed up for 2 years from exposure, with QFN and TSPOT repeated at months 3 and 6 from the first testing. RESULTS Of 104 exposed individuals, 75 enrolled in the study. There was a high degree of discordance among QFN, TSPOT and TST. This was seen at both the first time point and also over time in subjects who were retested. No patients had active TB at the baseline testing. None received treatment for latent TB infection. Over the following 2 years, no one developed TB disease. CONCLUSION This study suggests that there is a low risk of progression to active TB in low-incidence countries even in high-risk groups. This plus the degree of the test result discordance emphasises the complexities of managing TB in such settings as it is unclear which of these tests, if any, provides the best diagnostic accuracy.
Collapse
Affiliation(s)
- J Southern
- Public Health England, London, United Kingdom.
| | - S Sridhar
- Imperial College London, United Kingdom
| | - C-Y Tsou
- Public Health England, London, United Kingdom
| | - S Hopkins
- Royal Free London NHS Foundation Trust, United Kingdom
| | - S Collier
- Royal Free London NHS Foundation Trust, United Kingdom
| | | | - S Lozewicz
- North Middlesex University Hospital, United Kingdom
| | - A Lalvani
- Imperial College London, United Kingdom
| | - I Abubakar
- Public Health England, London, United Kingdom
| | - M Lipman
- University College London, United Kingdom
| |
Collapse
|
24
|
Pouwels KB, Robotham JV, McNulty CAM, Muller-Pebody B, Hopkins S. Prevalence of resistance to antibiotics in children's urinary Escherichia coli isolates estimated using national surveillance data. J Antimicrob Chemother 2018; 73:2268-2269. [PMID: 29726990 DOI: 10.1093/jac/dky159] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Affiliation(s)
- K B Pouwels
- Modelling and Economics Unit, National Infection Service, Public Health England, London, UK.,Department of Health Sciences, Global Health, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
| | - J V Robotham
- Modelling and Economics Unit, National Infection Service, Public Health England, London, UK
| | - C A M McNulty
- Primary Care Unit, Public Health England, Gloucester Royal Hospital, Gloucester, UK
| | - B Muller-Pebody
- Healthcare-Associated Infection and Antimicrobial Resistance Department, National Infection Service, Public Health England, London, UK
| | - S Hopkins
- Healthcare-Associated Infection and Antimicrobial Resistance Department, National Infection Service, Public Health England, London, UK.,Directorate of Infection, Royal Free London NHS Foundation Trust, London, UK
| |
Collapse
|
25
|
Coope CM, Verlander NQ, Schneider A, Hopkins S, Welfare W, Johnson AP, Patel B, Oliver I. An evaluation of a toolkit for the early detection, management, and control of carbapenemase-producing Enterobacteriaceae: a survey of acute hospital trusts in England. J Hosp Infect 2018. [PMID: 29530741 DOI: 10.1016/j.jhin.2018.03.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
BACKGROUND Following hospital outbreaks of carbapenemase-producing Enterobacteriaceae (CPE), Public Health England published a toolkit in December 2013 to promote the early detection, management, and control of CPE colonization and infection in acute hospital settings. AIM To examine awareness, uptake, implementation and usefulness of the CPE toolkit and identify potential barriers and facilitators to its adoption in order to inform future guidance. METHODS A cross-sectional survey of National Health Service (NHS) acute trusts was conducted in May 2016. Descriptive analysis and multivariable regression models were conducted, and narrative responses were analysed thematically and informed using behaviour change theory. FINDINGS Most (92%) acute trusts had a written CPE plan. Fewer (75%) reported consistent compliance with screening and isolation of CPE risk patients. Lower prioritization and weaker senior management support for CPE prevention were associated with poorer compliance. Awareness of the CPE toolkit was high and all trusts with patients infected or colonized with CPE had used the toolkit either as provided (32%), or to inform (65%) their own local CPE plan. Despite this, many respondents (80%) did not believe that the CPE toolkit guidance offered an effective means to prevent CPE or was practical to follow. CONCLUSION CPE prevention and control requires robust IPC measures. Successful implementation can be hindered by a complex set of factors related to their practical execution, insufficient resources and a lack of confidence in the effectiveness of the guidance. Future CPE guidance would benefit from substantive user involvement, processes for ongoing feedback, and regular guidance updates.
Collapse
Affiliation(s)
- C M Coope
- NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol, Bristol, UK; Public Health England, UK; University of Bristol, Bristol, UK.
| | | | - A Schneider
- NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol, Bristol, UK; University College London, London, UK
| | | | | | | | | | - I Oliver
- NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol, Bristol, UK; Public Health England, UK; University of Bristol, Bristol, UK
| |
Collapse
|
26
|
Broderick C, Hopkins S, Mack DJF, Aston W, Pollock R, Skinner JA, Warren S. Delays in the diagnosis and treatment of bone and joint tuberculosis in the United Kingdom. Bone Joint J 2018; 100-B:119-124. [DOI: 10.1302/0301-620x.100b1.bjj-2017-0357.r1] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Aims Tuberculosis (TB) infection of bones and joints accounts for 6.7% of TB cases in England, and is associated with significant morbidity and disability. Public Health England reports that patients with TB experience delays in diagnosis and treatment. Our aims were to determine the demographics, presentation and investigation of patients with a TB infection of bones and joints, to help doctors assessing potential cases and to identify avoidable delays. Patients and Methods This was a retrospective observational study of all adults with positive TB cultures on specimens taken at a tertiary orthopaedic centre between June 2012 and May 2014. A laboratory information system search identified the patients. The demographics, clinical presentation, radiology, histopathology and key clinical dates were obtained from medical records. Results A total of 31 adult patients were identified. Their median age was 37 years (interquartile range (IQR): 29 to 53); 21 (68%) were male; 89% were migrants. The main sites affected were joints (10, 32%), the spine (8, 26%) and long bones (6, 19%); 8 (26%) had multifocal disease. The most common presenting symptoms were pain (29/31, 94%) and swelling (26/28, 93%). ‘Typical’ symptoms of TB, such as fever, sweats and weight loss, were uncommon. Patients waited a median of seven months (IQR 3 to 13.5) between the onset of symptoms and referral to the tertiary centre and 2.3 months (IQR 1.6 to 3.4.)) between referral and starting treatment. Radiology suggested TB in 26 (84%), but in seven patients (23%) the initial biopsy specimens were not sent for mycobacterial culture, necessitating a second biopsy. Rapid Polymerase Chain Reaction-based testing for TB using Xpert MTB/RIF was performed in five patients; 4 (80%) tested positive for TB. These patients had a reduced time between the diagnostic biopsy and starting treatment than those whose samples were not tested (median eight days versus 36 days, p = 0.016). Conclusion Patients with bone and joint TB experience delays in diagnosis and treatment, some of which are avoidable. Maintaining a high index of clinical suspicion and sending specimens for mycobacterial culture are crucial to avoid missing cases. Rapid diagnostic tests reduce delays and should be performed on patients with radiological features of TB. Cite this article: Bone Joint J 2018;100-B:119–24.
Collapse
Affiliation(s)
- C. Broderick
- Directorate of Infection, Royal Free London
NHS Foundation Trust, Pond Street, London
NW3 2QG, UK
| | - S. Hopkins
- Directorate of Infection, Royal Free London
NHS Foundation Trust and Royal National Orthopaedic Hospital NHS
Trust, Pond Street, London
NW3 2QG, Brockley Hill, Stanmore, Middlesex
HA7 4LP, UK
| | - D. J. F. Mack
- Directorate of Infection, Royal Free London
NHS Foundation Trust and Royal National Orthopaedic Hospital NHS
Trust, Pond Street, London
NW3 2QG, Brockley Hill, Stanmore, Middlesex
HA7 4LP, UK
| | - W. Aston
- Royal National Orthopaedic Hospital NHS
Trust, Brockley Hill, Stanmore, Middlesex
HA7 4LP, UK
| | - R. Pollock
- Royal National Orthopaedic Hospital NHS
Trust, Brockley Hill, Stanmore, Middlesex
HA7 4LP, UK
| | - J. A. Skinner
- Royal National Orthopaedic Hospital NHS
Trust, Brockley Hill, Stanmore, Middlesex
HA7 4LP, UK
| | - S. Warren
- Directorate of Infection, Royal Free London
NHS Foundation Trust and Royal National Orthopaedic Hospital NHS
Trust, Pond Street, London
NW3 2QG, Brockley Hill, Stanmore, Middlesex
HA7 4LP, UK
| |
Collapse
|
27
|
Abstract
The link between low bone mineral density (BMD) scores leading to greater fracture risk is well established in the literature; what is not fully understood is the impact of total knee replacements/revisions or arthroplasties on BMD levels. This literature review attempts to answer this question. Several different databases using specific key terms were searched, with additional papers retrieved via bibliographic review. Based on the available evidence, total knee replacements/revisions and arthroplasties lower BMD and thus increase fracture risk. This review also addresses the possible implications of this research and possible options to reduce this risk.
Collapse
Affiliation(s)
- M. Gundry
- University of Exeter Medical School, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU UK
| | - S. Hopkins
- University of Exeter Medical School, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU UK
| | - K. Knapp
- University of Exeter Medical School, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU UK
| |
Collapse
|
28
|
Wilmore SMS, Kranzer K, Williams A, Makamure B, Nhidza AF, Mayini J, Bandason T, Metcalfe J, Nicol MP, Balakrishnan I, Ellington MJ, Woodford N, Hopkins S, McHugh TD, Ferrand RA. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in HIV-infected children in Zimbabwe. J Med Microbiol 2017; 66:609-615. [PMID: 28513417 PMCID: PMC5817228 DOI: 10.1099/jmm.0.000474] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Background Antimicrobial resistance is an emerging global health issue. Data on the epidemiology of multidrug-resistant organisms are scarce for Africa, especially in HIV-infected individuals who often have frequent contact with healthcare. We investigated the prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) carriage in stool among HIV-infected children attending an HIV outpatient department in Harare, Zimbabwe. Methods We recruited children who were stable on antiretroviral therapy (ART) attending a HIV clinic from August 2014 to June 2015. Information was collected on antibiotic use and hospitalization. Stool was tested for ESBL-E through combination disc diffusion. API20E identification and antimicrobial susceptibility was performed on the positive samples followed by whole genome sequencing. Results Stool was collected from 175/202 (86.6 %) children. Median age was 11 [inter-quartile range (IQR) 9–12] years. Median time on ART was 4.6 years (IQR 2.4–6.4). ESBL-Es were found in 24/175 samples (13.7 %); 50 % of all ESBL-Es were resistant to amoxicillin-clavulanate, 100 % to co-trimoxazole, 45.8 % to chloramphenicol, 91.6 % to ceftriaxone, 20.8 % to gentamicin and 62.5 % to ciprofloxacin. ESBL-Es variously encoded CTX-M, OXA, TEM and SHV enzymes. The odds of ESBL-E carriage were 8.5 times (95 % CI 2.2–32.3) higher in those on ART for less than one year (versus longer) and 8.5 times (95 % CI 1.1–32.3) higher in those recently hospitalized for a chest infection. Conclusion We found a 13.7 % prevalence of ESBL-E carriage in a population where ESBL-E carriage has not been described previously. Antimicrobial resistance (AMR) in Africa merits further study, particularly given the high HIV prevalence and limited diagnostic and therapeutic options available.
Collapse
Affiliation(s)
- S M S Wilmore
- Royal Free Hospital NHS Trust, London, UK.,London School of Hygiene and Tropical Medicine, London, UK.,UCL Centre for Clinical Microbiology, University College London, London, UK
| | - K Kranzer
- London School of Hygiene and Tropical Medicine, London, UK.,National German Mycobacterium Reference, Borstel, Germany
| | - A Williams
- Royal Free Hospital NHS Trust, London, UK
| | - B Makamure
- Biomedical Research and Training Institute, Harare, Zimbabwe
| | - A F Nhidza
- Biomedical Research and Training Institute, Harare, Zimbabwe
| | - J Mayini
- Biomedical Research and Training Institute, Harare, Zimbabwe
| | - T Bandason
- Biomedical Research and Training Institute, Harare, Zimbabwe
| | - J Metcalfe
- University of California, San Francisco, USA
| | - M P Nicol
- University of Cape Town, National Health Laboratory Service, Cape Town, South Africa
| | | | | | | | - S Hopkins
- Royal Free Hospital NHS Trust, London, UK.,Public Health England, London, UK
| | - T D McHugh
- UCL Centre for Clinical Microbiology, University College London, London, UK
| | - R A Ferrand
- London School of Hygiene and Tropical Medicine, London, UK.,Biomedical Research and Training Institute, Harare, Zimbabwe
| |
Collapse
|
29
|
Stern D, Cho MT, Chikarmane R, Willaert R, Retterer K, Kendall F, Deardorff M, Hopkins S, Bedoukian E, Slavotinek A, Schrier Vergano S, Spangler B, McDonald M, McConkie-Rosell A, Burton BK, Kim KH, Oundjian N, Kronn D, Chandy N, Baskin B, Guillen Sacoto MJ, Wentzensen IM, McLaughlin HM, McKnight D, Chung WK. Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizures. Clin Genet 2017; 92:221-223. [PMID: 28111752 DOI: 10.1111/cge.12956] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2016] [Revised: 12/05/2016] [Accepted: 12/06/2016] [Indexed: 02/04/2023]
Abstract
Graphical abstract key: ADHD, attention deficit hyperactivity disorder; ASD, atrial septal defect; DD, developmental delay; EEG, electroencephalogram; Ht, height; ID, intellectual disability; OCD, obsessive-compulsive disorder; OFC, open fontanelle; PDA, patent ductus arteriosis; PFO, patent foramen ovale; VSD, ventricular septal defect; Wt, weight.
Collapse
Affiliation(s)
- D Stern
- Department of Pediatrics, Columbia University Medical Center, New York, NY, USA
| | - M T Cho
- GeneDx, Gaithersburg, MD, USA
| | | | | | | | - F Kendall
- VMP Genetics, Roswell, GA, USA.,Department of Kinesiology, University of Georgia, Athens, GA, USA
| | - M Deardorff
- Department of Pediatrics, Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - S Hopkins
- Division of Neurology, The Children's Hospital of Philadelphia, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
| | - E Bedoukian
- Individualized Medical Genetics Center, Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - A Slavotinek
- Department of Pediatrics, UCSF Benioff Children's Hospital, University of California, San Francisco, CA, USA
| | - S Schrier Vergano
- Division of Medical Genetics and Metabolism, Children's Hospital of The King's Daughters, Norfolk, VA, USA
| | - B Spangler
- Division of Medical Genetics and Metabolism, Children's Hospital of The King's Daughters, Norfolk, VA, USA
| | - M McDonald
- Division of Medical Genetics, Duke University Medical Center, Durham, NC, USA
| | - A McConkie-Rosell
- Division of Medical Genetics, Duke University Medical Center, Durham, NC, USA
| | - B K Burton
- Division of Genetics, Birth Defects & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | - K H Kim
- Division of Genetics, Birth Defects & Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
| | | | - D Kronn
- New York Medical College, Valhalla, NY, USA
| | - N Chandy
- New York Medical College, Valhalla, NY, USA
| | | | | | | | | | | | - W K Chung
- Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.,Department of Medicine, Columbia University Medical Center, New York, NY, USA
| |
Collapse
|
30
|
Lyons O, Baguneid M, Barwick T, Bell R, Foster N, Homer-Vanniasinkam S, Hopkins S, Hussain A, Katsanos K, Modarai B, Sandoe J, Thomas S, Price N. Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC). J Vasc Surg 2017. [DOI: 10.1016/j.jvs.2016.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
31
|
Murphy ME, Shah NM, Bharucha T, Cash C, Cleverley JR, Cropley IM, Hopkins S, Lipman MCI. M17 Limited value of baseline chest radiography in adults with non-tuberculous mycobacteria. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
32
|
Lyons O, Baguneid M, Barwick T, Bell R, Foster N, Homer-Vanniasinkam S, Hopkins S, Hussain A, Katsanos K, Modarai B, Sandoe J, Thomas S, Price N. Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg 2016; 52:758-763. [DOI: 10.1016/j.ejvs.2016.09.007] [Citation(s) in RCA: 114] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 09/16/2016] [Indexed: 10/20/2022]
|
33
|
Freeman R, Ironmonger D, Puleston R, Hopkins K, Welfare W, Hope R, Staves P, Shemko M, Hopkins S, Cleary P, Patel B, Muller-Pebody B, Li X, Alvarez-Buylla A, Hawkey P, Johnson A, Woodford N, Oliver I. Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts. Clin Microbiol Infect 2016; 22:896-897. [DOI: 10.1016/j.cmi.2016.07.020] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2016] [Revised: 07/15/2016] [Accepted: 07/16/2016] [Indexed: 11/29/2022]
|
34
|
Bleiker J, Knapp K, Hopkins S, Johnston G. Compassionate care in radiography recruitment, education and training: A post-Francis Report review of the current literature and patient perspectives. Radiography (Lond) 2016. [DOI: 10.1016/j.radi.2015.12.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
35
|
Martin D, Howard J, Agarwal B, Rajalingam Y, Athan B, Bhagani S, Cropley I, Hopkins S, Mepham S, Rodger A, Warren S, Jacobs M. Ebola virus disease: the UK critical care perspective † †This Article is accompanied by Editorial Aew068. Br J Anaesth 2016; 116:590-6. [DOI: 10.1093/bja/aew098] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/22/2016] [Indexed: 11/15/2022] Open
|
36
|
Jan Mohamed HJ, Loy SL, Taib MNM, Karim NA, Tan SY, Appukutty M, Razak NA, Thielecke F, Hopkins S, Ong MK, Ning C, Tee ES. Erratum to: 'Characteristics associated with the consumption of malted drinks among Malaysian primary school children: findings from the MyBreakfast study'. BMC Public Health 2016; 16:162. [PMID: 26883422 PMCID: PMC4755016 DOI: 10.1186/s12889-016-2745-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2016] [Accepted: 01/19/2016] [Indexed: 11/24/2022] Open
Affiliation(s)
- Hamid Jan Jan Mohamed
- Nutrition Programme, School of Health Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.
| | - S L Loy
- KK Research Centre, KK Women's and Children's Hospital, Bukit Timah Road, Singapore, 229899, Singapore
| | - Mohd Nasir Mohd Taib
- Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor Darul Ehsan, Malaysia
| | - Norimah A Karim
- School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abd Aziz, 50300, Kuala Lumpur, Malaysia
| | - S Y Tan
- Department of Nutrition and Dietetics, School of Health Sciences, International Medical University, No.126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia
| | - M Appukutty
- Sports Science Programme, Faculty of Sports Science and Recreation, Universiti Teknologi MARA, 40450, Shah Alam, Selangor Darul Ehsan, Malaysia
| | - Nurliyana Abdul Razak
- Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor Darul Ehsan, Malaysia
| | - F Thielecke
- Cereal Partners Worldwide, Chemin du Viaduc 1. Prilly, Lausanne, 1008, Switzerland.,Nestlé Research Center, Vers chez les Blanc, 1000, Lausanne, Switzerland
| | - S Hopkins
- Cereal Partners Worldwide, Chemin du Viaduc 1. Prilly, Lausanne, 1008, Switzerland
| | - M K Ong
- Nestlé R&D Center, 2655633, 29 Quality Road, 618802, Singapore, Singapore
| | - C Ning
- Nestlé R&D Center, 2655633, 29 Quality Road, 618802, Singapore, Singapore
| | - E S Tee
- Nutrition Society of Malaysia, c/o Division of Human Nutrition, Institute for Medical Research, Kuala Lumpur, Malaysia
| |
Collapse
|
37
|
Ashiru-Oredope D, Budd EL, Bhattacharya A, Din N, McNulty CAM, Micallef C, Ladenheim D, Beech E, Murdan S, Hopkins S. Implementation of antimicrobial stewardship interventions recommended by national toolkits in primary and secondary healthcare sectors in England: TARGET and Start Smart Then Focus. J Antimicrob Chemother 2016; 71:1408-14. [PMID: 26869693 DOI: 10.1093/jac/dkv492] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2015] [Accepted: 12/22/2015] [Indexed: 12/13/2022] Open
Abstract
OBJECTIVES To assess and compare the implementation of antimicrobial stewardship (AMS) interventions recommended within the national AMS toolkits, TARGET and Start Smart Then Focus, in English primary and secondary healthcare settings in 2014, to determine the prevalence of cross-sector engagement to drive AMS interventions and to propose next steps to improve implementation of AMS. METHODS Electronic surveys were circulated to all 211 clinical commissioning groups (CCGs; primary sector) and to 146 (out of the 159) acute trusts (secondary sector) in England. Response rates were 39% and 63% for the primary and secondary sectors, respectively. RESULTS The majority of CCGs and acute trusts reported reviewing national AMS toolkits formally or informally (60% and 87%, respectively). However, only 13% of CCGs and 46% of acute trusts had developed an action plan for the implementation of these toolkits. Only 5% of CCGs had antimicrobial pharmacists in post; however, the role of specialist antimicrobial pharmacists continued to remain embedded within acute trusts, with 83% of responding trusts having an antimicrobial pharmacist at a senior grade. CONCLUSIONS The majority of healthcare organizations review national AMS toolkits; however, implementation of the toolkits, through the development of action plans to deliver AMS interventions, requires improvement. For the first time, we report the extent of cross-sector and multidisciplinary collaboration to deliver AMS interventions in both primary and secondary care sectors in England. Results highlight that further qualitative and quantitative work is required to explore mutual benefits and promote best practice. Antimicrobial pharmacists remain leaders for implementing AMS interventions across both primary and secondary healthcare sectors.
Collapse
Affiliation(s)
- D Ashiru-Oredope
- Antimicrobial Resistance Programme, Public Health England, London, UK
| | - E L Budd
- Antimicrobial Resistance Programme, Public Health England, London, UK
| | - A Bhattacharya
- Antimicrobial Resistance Programme, Public Health England, London, UK
| | - N Din
- Department of Pharmaceutics, UCL School of Pharmacy, UCL, London, UK
| | - C A M McNulty
- Primary Care Unit, Public Health England, Gloucester Royal Hospital, Gloucester, UK
| | - C Micallef
- Pharmacy Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK National Institute for Health Research Health Protection Research Unit, Healthcare Associated Infection and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, UK
| | - D Ladenheim
- Pharmacy Department, East & North Herts NHS Trust, Hertford, UK
| | - E Beech
- NHS Bath and North East Somerset Clinical Commissioning Group, Bath, UK NHS England Patient Safety Domain 5, London, UK
| | - S Murdan
- Department of Pharmaceutics, UCL School of Pharmacy, UCL, London, UK
| | - S Hopkins
- Antimicrobial Resistance Programme, Public Health England, London, UK
| | | |
Collapse
|
38
|
Jan Mohamed HJB, Loy SL, Mohd Taib MN, Karim NA, Tan SY, Appukutty M, Abdul Razak N, Thielecke F, Hopkins S, Ong MK, Ning C, Tee ES. Characteristics associated with the consumption of malted drinks among Malaysian primary school children: findings from the MyBreakfast study. BMC Public Health 2015; 15:1322. [PMID: 26718818 PMCID: PMC4697324 DOI: 10.1186/s12889-015-2666-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2015] [Accepted: 12/21/2015] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND The consumption of beverages contributes to diet quality and overall nutrition. Studies on malted drinks, one of the widely consumed beverage choices among children in Asia, however, have received limited attention. This study aimed to examine the prevalence of malted drink consumption and explored associations of sociodemographic characteristics, nutrient intakes, weight status and physical activity levels with malted drink consumption among primary school children in Malaysia. METHODS Data for this analysis were from the MyBreakfast Study, a national cross-sectional study conducted from April to October 2013 throughout all regions in Malaysia. A total of 2065 primary school children aged 6 to 12 years were included in the present analysis. Data on two days 24-h dietary recall or record, anthropometry, physical activity and screen time were recorded. Associations between malted drink consumption and related factors were examined using binary logistic regression, adjusting for region, area, gender, ethnicity and household income. RESULTS Among children aged 6 to 12 years, 73.5% reported consuming malted drinks for at least once per week. Consumption of malted drinks was significantly associated with region (χ(2) = 45.64, p < 0.001), gender (χ(2) = 4.41, p = 0.036) and ethnicity (χ(2) = 13.74, p = 0.008). Malted drink consumers had similar total energy intake but higher micronutrient intakes compared to non-consumers. High physical activity level (OR = 1.77, 95% CI = 1.06, 2.99) and lower screen time during weekends (OR = 0.93, 95% CI = 0.86, 0.99) were independently associated with malted drink consumption among 6 to 9 year-old children, but not among 10 to 12 year-old children. No association was observed between malted drink consumption and weight status. CONCLUSIONS Malted drink consumption is prevalent among Malaysian primary school children, particularly higher among boys, indigenous children and those who lived in the East Coast region of Malaysia. Consuming malted drinks is associated with higher micronutrient intakes and higher levels of physical activity, but not with body weight status.
Collapse
Affiliation(s)
- Hamid Jan B Jan Mohamed
- Nutrition Programme, School of Health Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.
| | - S L Loy
- KK Research Centre, KK Women's and Children's Hospital, Bukit Timah Road, Singapore, 229899, Singapore.
| | - Mohd Nasir Mohd Taib
- Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia.
| | - Norimah A Karim
- School of Healthcare Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abd Aziz, 50300, Kuala Lumpur, Malaysia.
| | - S Y Tan
- Department of Nutrition and Dietetics, School of Health Sciences, International Medical University, No.126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
| | - M Appukutty
- Sports Science Programme, Faculty of Sports Science and Recreation, Universiti Teknologi MARA, 40450, Shah Alam, Selangor Darul Ehsan, Malaysia.
| | - Nurliyana Abdul Razak
- Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor Darul Ehsan, Malaysia.
| | - F Thielecke
- Cereal Partners Worldwide, Chemin du Viaduc 1. Prilly, Lausanne, 1008, Switzerland.
- Nestlé Research Center, Vers chez les Blanc, 1000 Lausanne, Lausanne, Switzerland.
| | - S Hopkins
- Cereal Partners Worldwide, Chemin du Viaduc 1. Prilly, Lausanne, 1008, Switzerland.
| | - M K Ong
- Nestlé R&D Center, 2655633, 29 Quality Road, 618802, Singapore, Singapore.
| | - C Ning
- Nestlé R&D Center, 2655633, 29 Quality Road, 618802, Singapore, Singapore.
| | - E S Tee
- Nutrition Society of Malaysia, c/o Division of Human Nutrition, Institute for Medical Research, Kuala Lumpur, Malaysia.
| |
Collapse
|
39
|
Muller-Pebody B, Ladenheim D, Fuller C, Ashiru-Oredope D, Hopkins S. Validation of national hospital antimicrobial consumption data in England. Antimicrob Resist Infect Control 2015. [PMCID: PMC4475149 DOI: 10.1186/2047-2994-4-s1-p172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
40
|
Ryman TK, Boyer BB, Hopkins S, Philip J, Beresford SAA, Thompson B, Heagerty PJ, Pomeroy JJ, Thummel KE, Austin MA. Associations between diet and cardiometabolic risk among Yup'ik Alaska Native people using food frequency questionnaire dietary patterns. Nutr Metab Cardiovasc Dis 2015; 25:1140-1145. [PMID: 26607703 PMCID: PMC4684467 DOI: 10.1016/j.numecd.2015.08.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2015] [Revised: 08/09/2015] [Accepted: 08/10/2015] [Indexed: 10/23/2022]
Abstract
BACKGROUND AND AIMS In previous analyses, we identified three dietary patterns from food frequency questionnaire data among a sample of Yup'ik Alaska Native people living in Southwest Alaska: a "subsistence foods" dietary pattern and two market-based dietary patterns "processed foods" and "fruits and vegetables". In this analysis, we aimed to characterize the association between the dietary patterns and cardiometabolic (CM) risk factors (lipids, blood pressure, glucose, adiposity). METHODS AND RESULTS We used multilevel linear regression to estimate the mean of each CM risk factor, comparing participants in the 4th to the 1st quartile of each dietary pattern (n = 637). Models were adjusted for age, sex, past smoking, current smoking, and physical activity. Mean log triglyceride levels were significantly higher among participants in the 4th compared to the 1st quartile of the processed foods dietary pattern (β = 0.11). Mean HbA1c percent was significantly lower (β = -0.08) and mean diastolic blood pressure (DBP) mm Hg was significantly higher (β = 2.87) among participants in the 4th compared to the 1st quartile of the fruits and vegetables dietary pattern. Finally, mean log triglyceride levels and mean DBP mm Hg were significantly lower among participants in the 4th compared to the 1st quartile of the subsistence foods dietary pattern (β = -0.10 and β = -3.99 respectively). CONCLUSIONS We found increased CM risk, as reflected by increased triglycerides, associated with eating a greater frequency of processed foods, and reduced CM risk, as reflected by lower triglycerides and DBP, associated with eating a greater frequency of subsistence foods.
Collapse
Affiliation(s)
- T K Ryman
- University of Washington, Seattle, WA 98195, USA
| | - B B Boyer
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, AK 99775, USA
| | - S Hopkins
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, AK 99775, USA
| | - J Philip
- Center for Alaska Native Health Research, University of Alaska Fairbanks, Fairbanks, AK 99775, USA
| | | | - B Thompson
- University of Washington, Seattle, WA 98195, USA
| | - P J Heagerty
- University of Washington, Seattle, WA 98195, USA
| | - J J Pomeroy
- Marshfield Clinic Research Foundation, Marshfield, WI 54449, USA
| | - K E Thummel
- University of Washington, Seattle, WA 98195, USA
| | - M A Austin
- University of Washington, Seattle, WA 98195, USA.
| |
Collapse
|
41
|
Reilly JS, Coignard B, Price L, Godwin J, Cairns S, Hopkins S, Lyytikäinen O, Hansen S, Malcolm W, Hughes GJ. The reliability of the McCabe score as a marker of co-morbidity in healthcare-associated infection point prevalence studies. J Infect Prev 2015; 17:127-129. [PMID: 28989468 DOI: 10.1177/1757177415617245] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Accepted: 10/11/2015] [Indexed: 11/16/2022] Open
Abstract
This study aimed to ascertain the reliability of the McCabe score in a healthcare-associated infection point prevalence survey. A 10 European Union Member States survey in 20 hospitals (n = 1912) indicated that there was a moderate level of agreement (κ = 0.57) with the score. The reliability of the application of the score could be increased by training data collectors, particularly with reference to the ultimately fatal criteria. This is important if the score is to be used to risk adjust data to drive infection prevention and control interventions.
Collapse
Affiliation(s)
- J S Reilly
- Institute for Applied Health Research, Glasgow Caledonian University, Glasgow, UK
| | | | - L Price
- Institute for Applied Health Research, Glasgow Caledonian University, Glasgow, UK
| | - J Godwin
- Institute for Applied Health Research, Glasgow Caledonian University, Glasgow, UK
| | - S Cairns
- Health Protection Scotland, National Services Scotland, Glasgow, UK
| | | | | | - S Hansen
- Charité Universitätsmedizin, Germany
| | - W Malcolm
- Health Protection Scotland, National Services Scotland, Glasgow, UK
| | | |
Collapse
|
42
|
Lin C, Bruinooge S, Kirkwood K, Hershman D, Jemal A, Yu J, Guadagnolo B, Hopkins S, Goldstein M, Bajorin D, Giordano S, Kosty M, Arnone A, Hanley A, Stevens S, Olsen C. Association Between Geographic Access and Receipt of Radiation Therapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1484] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Abstract
BACKGROUND Tremendous progress has been made in the past 20 years in understanding the roles played by immunophilins, and in particular the cyclophilins, in supporting the replication cycles of human viruses. A growing body of genetic and biochemical evidence and data from clinical trials confirm that cyclophilins are essential cofactors that contribute to establishing a permissive environment within the host cell that supports the replication of HIV-1 and HCV. Cyclophilin A regulates HIV-1 replication kinetics and infectivity, modulates sensitivity to host restriction factors, and cooperates in the transit of the pre-integration complex into the nucleus of infected cells. Cyclophilin A is an essential cofactor whose expression supports HCV-specific RNA replication in human hepatocytes. GENERAL SIGNIFICANCE Peptidyl-prolyl isomerase inhibitors have been used in clinical trials to validate cyclophilins as antiviral targets for the treatment of HIV-1 and Chronic Hepatitis C virus infection and as molecular probes to identify the roles played by immunophilins in supporting the replication cycles of human viruses. SCOPE OF REVIEW This review summarizes emerging research that defines the functions of immunophilins in supporting the replication cycles of HIV-1, HCV, HBV, coronaviruses, and other viral pathogens and describes new information that suggests a role for immunophilins in regulating innate immune responses against chronic viral infection. MAJOR CONCLUSIONS The dependence on cyclophilins by evolutionarily distinct viruses for accomplishing various steps in replication such as viral entry, initiation of genomic nucleic acid replication, viral genome uncoating, nuclear import and nuclear entry, emphasizes the potential of cyclophilin inhibitors as therapeutic agents. This article is part of a Special Issue entitled Proline-directed Foldases: Cell Signaling Catalysts and Drug Targets.
Collapse
Affiliation(s)
- Sam Hopkins
- Department of Clinical Research, Autoimmune Technologies, New Orleans, LA 70112 USA.
| | - Philippe A Gallay
- Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
| |
Collapse
|
44
|
Ashiru-Oredope D, Hopkins S. Antimicrobial resistance: moving from professional engagement to public action. J Antimicrob Chemother 2015; 70:2927-30. [DOI: 10.1093/jac/dkv297] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Birch C, Knapp K, Hopkins S, Gallimore S, Rock B. SpineAnalyzer™ is an accurate and precise method of vertebral fracture detection and classification on dual-energy lateral vertebral assessment scans. Radiography (Lond) 2015. [DOI: 10.1016/j.radi.2015.02.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
46
|
Reilly JS, Price L, Godwin J, Cairns S, Hopkins S, Cookson B, Malcolm W, Hughes G, Lyytikaïnen O, Coignard B, Hansen S, Suetens C, National Participants in the ECDC pilot validation study C. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011. Euro Surveill 2015; 20. [DOI: 10.2807/1560-7917.es2015.20.8.21045] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- J S Reilly
- Glasgow Caledonian University, Glasgow, United Kingdom
| | - L Price
- Glasgow Caledonian University, Glasgow, United Kingdom
| | - J Godwin
- Glasgow Caledonian University, Glasgow, United Kingdom
| | - S Cairns
- Health Protection Scotland, Glasgow, United Kingdom
| | - S Hopkins
- Public Health England, London, United Kingdom
| | - B Cookson
- Public Health England, London, United Kingdom
- University College London, United Kingdom (current affiliation)
| | - W Malcolm
- Health Protection Scotland, Glasgow, United Kingdom
| | - G Hughes
- Public Health England, London, United Kingdom
| | - O Lyytikaïnen
- National Institute for Health and Welfare, Helsinki, Finland
| | - B Coignard
- Institut de Veille Sanitaire, Saint-Maurice, France
| | - S Hansen
- Charité University Medicine Berlin, Germany
| | - C Suetens
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | | |
Collapse
|
47
|
Chia S, Gandhi S, Joy A, Edwards S, Gorr M, Hopkins S, Kondejewski J, Ayoub J, Califaretti N, Rayson D, Dent S. Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer. Curr Oncol 2015; 22:33-48. [PMID: 25684987 PMCID: PMC4324342 DOI: 10.3747/co.22.2393] [Citation(s) in RCA: 83] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
UNLABELLED The pi3k/Akt/mtor (phosphatidylinositol 3 kinase/ Akt/mammalian target of rapamycin) signalling pathway is an established driver of oncogenic activity in human malignancies. Therapeutic targeting of this pathway holds significant promise as a treatment strategy. Everolimus, an mtor inhibitor, is the first of this class of agents approved for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Everolimus has been associated with significant improvements in progression-free survival; however, it is also associated with increased toxicity related to its specific mechanism of action. METHODS A comprehensive review of the literature conducted using a focused medline search was combined with a search of current trials at http://ClinicalTrials.gov/. Summary tables of the toxicities of the various classes of pi3k/Akt/mtor inhibitors were created. A broad group of Canadian health care professionals was assembled to review the data and to produce expert opinion and summary recommendations for possible best practices in managing the adverse events associated with these pathway inhibitors. RESULTS Differing toxicities are associated with the various classes of pi3k/Akt/mtor pathway inhibitors. The most common unique adverse events observed in everolimus clinical trials in breast cancer include stomatitis (all grades: approximately 60%), noninfectious pneumonitis (15%), rash (40%), hyperglycemia (15%), and immunosuppression (40%). To minimize grades 3 and 4 toxicities and to attempt to attain optimal outcomes, effective management of those adverse events is critical. Management should be interdisciplinary and should use approaches that include education, early recognition, active intervention, and potentially prophylactic strategies. DISCUSSION Everolimus likely represents the first of many complex oral targeted therapies for the treatment of breast cancer. Using this agent as a template, it is essential to establish best practices involving and integrating multiple disciplines for the management of future pi3k/Akt/mtor signalling pathway inhibitors.
Collapse
Affiliation(s)
- S. Chia
- Department of Medical Oncology, BC Cancer Agency, Vancouver, BC
| | - S. Gandhi
- Sunnybrook Health Sciences Centre and University of Toronto, Toronto, ON
| | - A.A. Joy
- Department of Oncology, Division of Medical Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB
| | | | - M. Gorr
- Royal Victoria Regional Health Centre, Barrie, ON
| | - S. Hopkins
- Royal Victoria Regional Health Centre, Barrie, ON
| | | | - J.P. Ayoub
- Centre hospitalier de l’Université de Montréal– Hôpital Notre-Dame, Montreal, QC
| | | | - D. Rayson
- Division of Medical Oncology, Dalhousie University, and Atlantic Clinical Cancer Research Unit, Halifax, NS
| | - S.F. Dent
- The Ottawa Hospital Cancer Centre, Ottawa, ON
| |
Collapse
|
48
|
Sewell J, Capocci S, Johnson J, Solamalai A, Hopkins S, Cropley I, Webster DP, Lipman M. Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis. J Infect 2014; 70:317-23. [PMID: 25452045 DOI: 10.1016/j.jinf.2014.10.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2014] [Revised: 08/11/2014] [Accepted: 10/07/2014] [Indexed: 10/24/2022]
Abstract
OBJECTIVES Testing for HIV is a standard of care for people with active tuberculosis (TB). People investigated for TB in the UK often originate from areas with a high prevalence of HIV and other blood borne viruses (BBV). However, assessment for these infections is patchy. We determined the yield and costs of different testing strategies for BBV in a UK TB clinic. METHODS Since 2009, it has been routine to test all TB clinic attendees. Demographic, clinical and virological data were retrospectively extracted from patient notes and hospital databases. RESULTS Over 3 years, 1036 people were assessed in the TB service. 410 had a final diagnosis of active TB. HIV testing of the latter population diagnosed 27 new HIV cases at a cost of £3017. When BBV testing was offered to all clinic attendees, a further 6 (total 33) new HIV, 5 Hepatitis B (HBV) and 2 Hepatitis C (HCV) diagnoses were made at a total cost of £22,170. CONCLUSIONS We have identified previously undiagnosed HIV, HBV and HCV in a TB clinic population. Our data suggest that despite increasing upfront expense, the associated yield argues strongly for BBV testing to be offered to all patients being investigated for possible TB, irrespective of their final diagnosis.
Collapse
Affiliation(s)
- J Sewell
- Department of Health and Population Sciences, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom.
| | - S Capocci
- Department of Respiratory Medicine, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
| | - J Johnson
- Department of Respiratory Medicine, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
| | - A Solamalai
- North Central London TB Service, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
| | - S Hopkins
- Department of Infectious Diseases, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
| | - I Cropley
- Department of Infectious Diseases, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
| | - D P Webster
- Department of Virology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom.
| | - M Lipman
- Department of Respiratory Medicine, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, United Kingdom; University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom.
| |
Collapse
|
49
|
Sharp H, Pfau T, Hopkins S. The Effect of Hindlimb Studs on Movement Symmetry in Horses During Lungeing. Equine Vet J 2014. [DOI: 10.1111/evj.12323_45] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- H. Sharp
- The Royal Veterinary College; Hawkshead Lane, North Mymms Hatfield Hertfordshire UK
| | - T. Pfau
- The Royal Veterinary College; Hawkshead Lane, North Mymms Hatfield Hertfordshire UK
| | - S. Hopkins
- The Royal Veterinary College; Hawkshead Lane, North Mymms Hatfield Hertfordshire UK
| |
Collapse
|
50
|
Williams K, Hopkins S, Turbitt D, Seng C, Cookson B, Patel BC, Manuel RJ. Survey of neonatal unit outbreaks in North London: identifying causes and risk factors. J Hosp Infect 2014; 88:149-55. [PMID: 25146223 DOI: 10.1016/j.jhin.2014.06.012] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2013] [Accepted: 06/17/2014] [Indexed: 10/25/2022]
Abstract
BACKGROUND This survey was undertaken after a number of neonatal unit (NNU) outbreaks were reported to the North London health protection teams (HPTs). AIM To determine the diversity of the outbreaks, ascertain potential sources and contributing factors, and identify the investigative procedures followed and control measures implemented. METHODS Using a structured questionnaire, information from the HPT database was collected for all NNU outbreaks reported between January 2010 and February 2011. FINDINGS Ten outbreaks were identified from seven hospitals in 14 months. There was one para-influenza outbreak, seven Staphylococcus aureus [including six meticillin-resistant S. aureus (MRSA)] outbreaks, and two Gram-negative outbreaks. Potential sources of transmission identified for the MRSA outbreaks were healthcare worker (HCW)-assisted transmission (N = 2) and mother-to-baby transmission with onward HCW-assisted transmission (N = 3). An environmental source with onward HCW-assisted transmission was documented for one of the Gram-negative outbreaks. Interventions included patient screening and enhanced cleaning (N = 10), isolating/cohorting affected neonates (N = 9), barrier nursing (N = 6), staff movement restrictions (N = 5), hand hygiene audits (N = 4), staff screening (N = 4), household contact screening (N = 3) and environmental sampling (N = 3). Potential contributing factors included inadequate staffing levels, cluttered unit, inadequate sterilization of communal milk-expressing equipment and inappropriate follow-up of MRSA results. CONCLUSION This survey determined the diversity of NNU outbreaks in North London, and highlighted the importance of a multi-faceted approach to outbreak control. These data will assist in the development of clinical standards for the prevention, control and reporting of NNU outbreaks, and guidance for best practice in NNUs.
Collapse
Affiliation(s)
- K Williams
- Public Health Laboratory London, Public Health England, London, UK.
| | - S Hopkins
- Health Protection Services Colindale, Public Health England, London, UK
| | - D Turbitt
- North East and North Central London Health Protection Team, Public Health England, London, UK
| | - C Seng
- North West London Health Protection Team, Public Health England, London, UK
| | - B Cookson
- Microbiology Services Colindale, Public Health England, London, UK
| | - B C Patel
- Public Health Laboratory London, Public Health England, London, UK
| | - R J Manuel
- Public Health Laboratory London, Public Health England, London, UK
| |
Collapse
|